Company · CIK 0001553643 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
RELMADA THERAPEUTICS, INC. · RLMD
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 9, 2026 PForm 4 → | Sep 11, 7:30 am EDT | Maged ShenoudaChief Financial Officer | 200,000 | $4.22 | $843,990 | 1,000,000 | +25.0% | |
| Sep 9, 2026 PForm 4 → | Sep 11, 7:30 am EDT | Sergio TraversaChief Executive Officer, Director | 200,000 | $4.14 | $828,000 | 1,500,000 | +15.4% |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.